The long term goal of this research is to define molecular mechanisms involved in the regulation of cell growth and development by insulin. The signal transduction pathways involved in these processes are not fully understood, through important integral components of several insulin-stimulated pathways have been identified and characterized. The central hypothesis of this proposal is that multiple, distinct signals manage from the insulin receptor (IR) cytoplasmic domain upon activation of the receptor tyrosine kinase, and that those signals act separately and/or in combination to elicit the pleiotropic effects on cell fate and metabolism that are characteristic of insulin action. This hypothesis will be tested by analysis of putative effectors of insulin action and manipulation of a chimeric receptor encoding the extracellular ligand binding domain of the colony-stimulation factor-1 receptor (CSF1R) and the cytoplasmic domain of the insulin receptor. Expression of the CSF1R/1R allows CSF-1 to mimic the ability of insulin and IGF I to initiate adipoblast differentiation and activate glucose transport without activation of endogenous insulin receptors Mutations within the cytoplasmic domain of the CSF1R/IR have been useful in examining potential intracellular mediators of insulin action. This model system will be used to examine the molecular mechanisms used by insulin and IGFI to regulate cell growth and development with emphasis on the following: The contribution of IR effectors and pathways to the mitogenic and differentiation-inducing effects of insulin. The potential of IR effectors to manipulate adipocyte gene expression and function. The mechanisms used by IR effectors to transmit insulin-induced survival signals.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK052809-07
Application #
6736310
Study Section
Metabolism Study Section (MET)
Program Officer
Haft, Carol R
Project Start
1997-09-01
Project End
2006-02-28
Budget Start
2004-03-01
Budget End
2005-02-28
Support Year
7
Fiscal Year
2004
Total Cost
$227,851
Indirect Cost
Name
University of Nebraska Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198
Kortum, Robert L; Fernandez, Mario R; Costanzo-Garvey, Diane L et al. (2014) Caveolin-1 is required for kinase suppressor of Ras 1 (KSR1)-mediated extracellular signal-regulated kinase 1/2 activation, H-RasV12-induced senescence, and transformation. Mol Cell Biol 34:3461-72
Henry, MaLinda D; Costanzo-Garvey, Diane L; Klutho, Paula J et al. (2014) Obesity-dependent dysregulation of glucose homeostasis in kinase suppressor of ras 2-/- mice. Physiol Rep 2:
Costanzo-Garvey, Diane L; Pfluger, Paul T; Dougherty, Michele K et al. (2009) KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity. Cell Metab 10:366-78
Kortum, Robert L; Johnson, Heidi J; Costanzo, Diane L et al. (2006) The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence. Mol Cell Biol 26:2202-14
Kortum, Robert L; Costanzo, Diane L; Haferbier, Jamie et al. (2005) The molecular scaffold kinase suppressor of Ras 1 (KSR1) regulates adipogenesis. Mol Cell Biol 25:7592-604
Kortum, Robert L; Lewis, Robert E (2004) The molecular scaffold KSR1 regulates the proliferative and oncogenic potential of cells. Mol Cell Biol 24:4407-16
Brennan, Jennifer A; Volle, Deanna J; Chaika, Oleg V et al. (2002) Phosphorylation regulates the nucleocytoplasmic distribution of kinase suppressor of Ras. J Biol Chem 277:5369-77
Nguyen, AnhCo; Burack, W Richard; Stock, Jeffrey L et al. (2002) Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo. Mol Cell Biol 22:3035-45
Boehm, J E; Chaika, O V; Lewis, R E (1999) Rac-dependent anti-apoptotic signaling by the insulin receptor cytoplasmic domain. J Biol Chem 274:28632-6
Chaika, O V; Chaika, N; Volle, D J et al. (1999) Mutation of tyrosine 960 within the insulin receptor juxtamembrane domain impairs glucose transport but does not inhibit ligand-mediated phosphorylation of insulin receptor substrate-2 in 3T3-L1 adipocytes. J Biol Chem 274:12075-80

Showing the most recent 10 out of 13 publications